The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index
|
Sep 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression
|
Aug 2017
|
Exp Hematol
|
myelodysplastic syndromes (MDS)
|
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
|
Jan 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
The molecular pathogenesis of the myelodysplastic syndromes
|
Jan 2015
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
The multifaceted nature of myelodysplastic syndromes: clinical, molecular, and biological prognostic features
|
Jul 2013
|
J Natl Compr Canc Netw
|
myelodysplastic syndromes (MDS)
|
The mutational landscape of paroxysmal nocturnal hemoglobinuria revealed: new insights into clonal dominance
|
Sep 2014
|
J Clin Invest
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
The myelodysplastic syndrome as a prototypical epigenetic disease.
|
May 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
The Myelodysplastic Syndromes (MDS): A personal recollection of four decades of classification and prognostic scoring systems.
|
Apr 2013
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system
|
Oct 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
The Myelodysplastic Syndromes: The Era Of Understanding
|
Sep 2014
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|